SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-23-001577
Filing Date
2023-02-10
Accepted
2023-02-10 16:15:46
Documents
59
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q edsa_10q.htm   iXBRL 10-Q 553007
2 LEASE EXTENDING AND AMENDING AGREEMENT edsa_ex103.htm EX-10.3 20740
3 CERTIFICATION edsa_ex311.htm EX-31.1 11545
4 CERTIFICATION edsa_ex312.htm EX-31.2 9362
5 CERTIFICATION edsa_ex321.htm EX-32.1 3651
6 CERTIFICATION edsa_ex322.htm EX-32.2 3625
  Complete submission text file 0001654954-23-001577.txt   3129615

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA edsa-20221231.xsd EX-101.SCH 39105
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE edsa-20221231_lab.xml EX-101.LAB 209358
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE edsa-20221231_cal.xml EX-101.CAL 32976
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE edsa-20221231_pre.xml EX-101.PRE 170992
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE edsa-20221231_def.xml EX-101.DEF 78847
53 EXTRACTED XBRL INSTANCE DOCUMENT edsa_10q_htm.xml XML 450191
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37619 | Film No.: 23612062
SIC: 2834 Pharmaceutical Preparations